Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRIT Capital Partners Regulatory News (RCP)

Share Price Information for RIT Capital Partners (RCP)

Share Price is delayed by 15 minutes
Get Live Data
2,295.00    -10.00 (-0.43%)
Bid:
2,295.00
Ask:
2,305.00
Spread: 10.00 (0.436%)
Market Cap: £3.11b
RCP Live PriceLast checked at - London Stock Exchange

Intraday RIT Capital Partners Share Chart

Net Asset Value(s)

17 May 2023 07:00

RNS Number : 6319Z
RIT Capital Partners PLC
17 May 2023
 

RIT CAPITAL PARTNERS PLC (LEI: P31Q1NLTW35JJGHA4667)

17 May 2023

 

Net Asset Value

 

The unaudited diluted net asset value (NAV) of RIT Capital Partners plc as at 30 April 2023 (with debt at fair value) was 2,367p per £1 ordinary share (31 March 2023: 2,405p). This is after deduction of the first interim dividend of 19p per £1 ordinary share paid on 28 April 2023.

 

April 2023 Highlights

 

Global equity markets were broadly stable in April as Q1 economic indicators and quarterly earnings remained healthy, while overall sentiment was impacted by the prospects for further rate rises and continued concerns around banking system stability. Against this backdrop, we continued to maintain a cautious net quoted equity exposure of around 37%, at the low end of our historical range.

 

· The Quoted Equities book saw healthy performance from Japan and Healthcare, partly offset by weakness in China.

· In our Private Investments book, ~12% of our private funds have reported valuations to 31 March and ~86% are held at 31 December valuations. Our second largest direct private holding, Webull, completed an equity issuance in April at a price above carrying value.

· Our Uncorrelated Strategies showed healthy performance, helped by positive contributions from market neutral strategies and continued momentum in gold.

· The key headwind during the period was currency movements, with Sterling recording gains against major currencies including the Dollar, the Euro and the Yen.

· Our share price benefitted from a narrowing of the discount, with the shares closing the month at a discount to NAV of -15.3%. The Board continued to take advantage of the discount, buying back 1.1 million shares in April. This directly benefits shareholders through the accretive impact to NAV per share.

· The portfolio continues to hold a substantial liquidity balance. As at 30 April, total cash and short-term gilts were approximately £358 million.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NAVQQLFFXELXBBE
Date   Source Headline
29th Jan 20247:00 amRNSTransaction in Own Shares
26th Jan 20247:00 amRNSTransaction in Own Shares
25th Jan 20247:00 amRNSTransaction in Own Shares
24th Jan 20247:00 amRNSTransaction in Own Shares
23rd Jan 20247:00 amRNSTransaction in Own Shares
22nd Jan 20247:00 amRNSTransaction in Own Shares
19th Jan 20247:00 amRNSTransaction in Own Shares
18th Jan 20247:00 amRNSTransaction in Own Shares
17th Jan 20247:00 amRNSTransaction in Own Shares
16th Jan 20247:00 amRNSTransaction in Own Shares
15th Jan 20247:00 amRNSTransaction in Own Shares
12th Jan 20247:00 amRNSTransaction in Own Shares
11th Jan 20247:00 amRNSTransaction in Own Shares
10th Jan 20247:00 amRNSTransaction in Own Shares
9th Jan 20247:00 amRNSTransaction in Own Shares
8th Jan 20247:00 amRNSTransaction in Own Shares
4th Jan 20245:00 pmRNSCompany Announcement
2nd Jan 20242:10 pmRNSTotal Voting Rights
2nd Jan 20247:00 amRNSTransaction in Own Shares
29th Dec 202312:56 pmRNSShare Buyback Management
20th Dec 20237:00 amRNSTransaction in Own Shares
19th Dec 20237:00 amRNSTransaction in Own Shares
18th Dec 20237:00 amRNSNet Asset Value(s)
14th Dec 20237:00 amRNSTransaction in Own Shares
13th Dec 20237:00 amRNSTransaction in Own Shares
12th Dec 20237:00 amRNSTransaction in Own Shares
11th Dec 20237:00 amRNSTransaction in Own Shares
8th Dec 20237:00 amRNSTransaction in Own Shares
5th Dec 20237:00 amRNSTransaction in Own Shares
4th Dec 20237:00 amRNSTransaction in Own Shares
1st Dec 202311:32 amRNSTotal Voting Rights
1st Dec 20237:00 amRNSTransaction in Own Shares
30th Nov 20237:00 amRNSTransaction in Own Shares
27th Nov 20237:00 amRNSTransaction in Own Shares
20th Nov 20237:00 amRNSTransaction in Own Shares
17th Nov 20237:00 amRNSNet Asset Value(s)
14th Nov 20237:00 amRNSTransaction in Own Shares
13th Nov 20237:00 amRNSTransaction in Own Shares
9th Nov 20237:00 amRNSTransaction in Own Shares
8th Nov 20237:00 amRNSTransaction in Own Shares
7th Nov 20237:00 amRNSTransaction in Own Shares
6th Nov 20233:54 pmRNSComposition of Board Committee
1st Nov 20232:11 pmRNSTotal Voting Rights
1st Nov 20237:00 amRNSTransaction in Own Shares
31st Oct 20237:00 amRNSTransaction in Own Shares
30th Oct 20237:00 amRNSTransaction in Own Shares
27th Oct 20237:00 amRNSTransaction in Own Shares
26th Oct 20237:00 amRNSTransaction in Own Shares
25th Oct 20237:00 amRNSTransaction in Own Shares
24th Oct 20237:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.